The BM of allergic subjects releases increased amounts of CD34+ progenitor cells that migrate to the sites of allergic inflammation (2); these cells are readily detectable in the bronchial mucosa and the sputum of asthmatic patients, in nasal polyps and in the lesional skin of atopic dermatitis patients (13, 16). Here, CD34 is linked to nasal cavity polyp.